Central African Republic vs Senegal: Tuberculosis treatment success rate by type
Central African Republic
89
in 2023
Senegal
89
in 2023
Central African Republic rank
54th
Senegal rank
54th
Tuberculosis treatment success rate by type over time
- Central African Republic
- Senegal
How they compare
Central African Republic currently reports 89 against 89 in Senegal, a difference of 0.
The two have swapped places 6 times across 23 shared years of data; in 1995 it was Senegal ahead.
Central African Republic ranks 54th and Senegal ranks 54th of 194 countries.
Senegal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Central African Republic | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37 | 44 | 7 | Senegal |
| 2000s | 64 | 69.12 | 5.12 | Senegal |
| 2010s | 72 | 86.2 | 14.2 | Senegal |
| 2020s | 85.25 | 87.25 | 2 | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Central African Republic or Senegal?
- Central African Republic, at 89 against 89 in Senegal as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Central African Republic and Senegal?
- 0, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Senegal?
- 23 years are reported by both, from 1995 to 2023.
- How do Central African Republic and Senegal rank globally for tuberculosis treatment success rate by type?
- Central African Republic ranks 54th and Senegal ranks 54th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.